Morning akinesia in Parkinson's disease: challenges and solutions
نویسندگان
چکیده
منابع مشابه
Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease
BACKGROUND In patients with motor fluctuations complicating Parkinson's disease (PD), delays in time-to-ON with levodopa are common. This open-label study aimed to assess the effect of apomorphine on time-to-ON in PD patients with morning akinesia. METHODS The safety population included 127 enrolled patients, and the full analysis set (FAS) included 88 patients. Patients completed a 7-day lev...
متن کامل(Challenges and Solutions)
This article tries to inspect the delusion of Shiite-o-phobia as one of the most important threats for Islamic Awakening. How it has appeared and how it should be handled is the most important concern of this article. The author believes that following the emergence of Islamic Awakening in Iran, strategists of international hegemony have figured out the high potential of Shiites' soft power to ...
متن کاملTransplant coronary heart disease: challenges and solutions
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be f...
متن کاملPerianal Crohn’s disease: challenges and solutions
Perianal Crohn's disease affects a significant number of patients with Crohn's disease and is associated with poor quality of life. The nature of the disease, compounded by presentation of various disease severities, has made the treatment of perianal Crohn's disease difficult. The field continues to evolve with the use of both historical and contemporary solutions to address the challenges ass...
متن کاملManaging refractory Crohn’s disease: challenges and solutions
The goals of treatment for active Crohn's disease (CD) are to achieve clinical remission and improve quality of life. Conventional therapeutics for moderate-to-severe CD include 5-aminosalicylic acid, corticosteroids, purine analogs, azathioprine, and 6-mercaptopurine. Patients who fail to respond to conventional therapy are treated with tumor necrosis factor (TNF)-α inhibitors such as inflixim...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Parkinsonism and Restless Legs Syndrome
سال: 2016
ISSN: 1927-7733
DOI: 10.2147/jprls.s83276